Candel Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Candel Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q3 2024.
  • Candel Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 3.21K %.
  • Candel Therapeutics, Inc. annual Return On Equity for 2023 was -143 %, a 325% decline from 2022.
  • Candel Therapeutics, Inc. annual Return On Equity for 2022 was -33.6 %, a 86.9% increase from 2021.
  • Candel Therapeutics, Inc. annual Return On Equity for 2021 was -256 %, a 320% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 3.21K +3.3K Jul 1, 2024 Sep 30, 2024
Q2 2024 -629 -554 -732% Apr 1, 2024 Jun 30, 2024
Q1 2024 -206 -153 -285% Jan 1, 2024 Mar 31, 2024
Q4 2023 -143 -109 -325% Oct 1, 2023 Dec 31, 2023
Q3 2023 -90.5 -70.3 -348% Jul 1, 2023 Sep 30, 2023
Q2 2023 -75.6 -44.4 -142% Apr 1, 2023 Jun 30, 2023
Q1 2023 -53.6 +34.5 +39.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -33.6 +222 +86.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -20.2 Jul 1, 2022 Sep 30, 2022
Q2 2022 -31.2 Apr 1, 2022 Jun 30, 2022
Q1 2022 -88.1 Jan 1, 2022 Mar 31, 2022
Q4 2021 -256 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.